Evaluation of GM-CSF and AS01B Adjuvants in a Phase I/IIa Trial of a Therapeutic CMV Vaccine (VBI-1901) Against Recurrent Glioblastoma (GBM)

Conference: 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Date: June 8, 2021